CSIMarket
 


Agex Therapeutics Inc   (AGE)
Other Ticker:  
 

Cumulative Agex Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

AGE's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

AGE Quick Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth 165.65 % 139.19 % 33.69 % 54.6 % 131.23 %
Y / Y Cash & cash equivalent Growth -62.82 % -52.05 % -11.76 % -24.23 % -13.23 %
Quick Ratio for Trailing Twelve Months Period 0.03 0.04 0.07 0.08 0.09
Total Ranking # 3876 # 3949 # 4382 # 4164 # 4924
Seq. Current Liabilities Growth 12.52 % 143.15 % 8.25 % -10.3 % 1.32 %
Seq. Cash & cash equivalent Growth -6.79 % -56.59 % 38.41 % -33.62 % 20.21 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Due to increase in Current Liabilities in the II. Quarter to $24 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.03 below Agex Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 521 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Agex Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about AGE
Quick Ratio AGE in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 522
Sector # 1070
S&P 500 # 4001


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.78 0.54 0.03
(Sep 30 2019)   (Jun 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Bioxytran Inc   0.07 
Cytodyn inc   0.06 
Evofem Biosciences Inc   0.05 
Aeon Biopharma inc   0.05 
Janone Inc   0.04 
Sunwin Stevia International Inc.  0.04 
Cnbx Pharmaceuticals Inc   0.03 
Biostax Corp  0.03 
Statera Biopharma Inc fka Cytocom Inc   0.03 
Agex Therapeutics Inc   0.03 
Emmaus Life Sciences Inc   0.03 
Innovation1 Biotech Inc   0.02 
Earth Science Tech Inc   0.02 
Skinvisible Inc   0.02 
Axim Biotechnologies Inc   0.02 
Rebus Holdings Inc   0.02 
Sangui Biotech International Inc  0.02 
Oncotelic Therapeutics Inc   0.02 
Cell Source Inc   0.02 
Avenir Wellness Solutions Inc   0.02 
Cen Biotech Inc  0.02 
Bespoke Extracts Inc   0.01 
Wellness Center Usa Inc  0.01 
Adhera Therapeutics Inc   0.01 
Intellipharmaceutics International Inc   0.01 
American Bio Medica Corporation  0.01 
Novaccess Global Inc   0.01 
Propanc Biopharma Inc   0.01 
Bioadaptives Inc   0.01 
Provectus Biopharmaceuticals Inc   0.01 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com